(SHANGHAI, China, June 27, 2022) – Fosun Pharma and Amgen today jointly announced a collaboration and license agreement for Fosun Pharma for the commercialization of Amgen’s Otezla^® and Parsabiv^® in the Chinese Mainland. The collaboration will enable Amgen to bring the two innovative medicines to Chinese patients with psoriasis and chronic kidney d

(16 June 2022, Shanghai, China) 16 June 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or “the Group”; Stock Code: 600196.SH, 02196.HK), a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China, announced that Fosun Pharma presents a corporate overview at the BIO International Convent

(21 June 2022, Shanghai, China) During the BioNJ's 29th Annual Dinner Meeting & Innovation Celebration earlier this month, Fosun Pharma was awarded the Heart of BioNJ with the COVID-19 RT-PCR Detection Kit which was independently developed by its subsidiary company Fosun Diagnostics. The organizer BioNJ said in the award review that the awards were presented to BioNJ member

(24 June 2022) Fosun International Limited (HKEX stock code: 00656, “Fosun International”) said S&P Global Rating has published a report yesterday, stating that Fosun has adequate resources to meet its upcoming debt maturities over the next six to 12 months.S&P Global Rating said in yesterday’s report that it believed the company could rely on asset monetization and s

(23 June, 2022, Hong Kong) The world's leading index company, FTSE Russell, recently announced the latest ESG (Environmental, Social and Governance) rating results of Fosun International Limited (HKEX stock code: 00656) (“Fosun International”). Fosun International's FTSE Russell ESG rating has improved for two consecutive years, outperforming the in

(23 June 2022) Morgan Stanley has recently released a research report about Fosun International to reiterate its OVERWEIGHT Rating. An analyst who is a key opinion leader (KOL) has made an in-depth analysis on Bloomberg terminal about Fosun International after the research house has released the report.The following is the article extracted from the Bloomberg terminal post:Morgan Stanley just rel

(Hong Kong, 22 June 2022), On 22 June, Fosun International Limited ((HKEX stock code: 00656, “Fosun International”) announced an update on outstanding tender offer to accept Any-and-All for full outstanding principal amount of its only two offshore bonds maturing this year. The two offshore bonds are FOSUNI 5.5% 2023 US dollar bond puttable in August this year,

(21 June 2022) Recently, Henlius’ Songjiang First Plant in Shanghai received QP Declaration on its Good Manufacturing Practice (GMP) equivalence to European Union (EU) GMP. It declared that the quality management system of Songjiang First Plant is in line with EU GMP. In April 2022, Songjiang First Plant has obtained the GMP certification by Shanghai Medical Products Administra

From June 13-16, 2022, the 2022 Biotechnology Innovation Organization International Convention (「BIO 2022」) was held in San Diego, California, USA. The conference attracted more than 3,000 exhibitors, as well as many global industry leaders and top research scholars. At the San Diego Convention Center’s booth 5107, Henlius showcased a wide range of in